Jaeson Calla
Affiliations: | 2017- | Pediatrics | University of California, San Diego, La Jolla, CA |
Google:
"Jaeson Calla"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wang L, Bohmer MJ, Wang J, et al. (2024) Discovery of Potent Antimalarial Type II Kinase Inhibitors with Selectivity over Human Kinases. Journal of Medicinal Chemistry |
| Mittal N, Davis C, McLean P, et al. (2023) Human nuclear hormone receptor activity contributes to malaria parasite liver stage development. Cell Chemical Biology. 30: 486-498.e7 |
| Almaliti J, Fajtová P, Calla J, et al. (2023) Development of Potent and Highly Selective Epoxyketone-based Plasmodium Proteasome Inhibitors. Chemistry (Weinheim An Der Bergstrasse, Germany) |
| Beutler N, Pholcharee T, Oyen D, et al. (2022) A novel CSP C-terminal epitope targeted by an antibody with protective activity against Plasmodium falciparum. Plos Pathogens. 18: e1010409 |
| Rocamora F, Gupta P, Istvan ES, et al. (2021) PfMFR3: A Multidrug-Resistant Modulator in . Acs Infectious Diseases |
| Abraham M, Gagaring K, Marino ML, et al. (2020) Probing the Open Global Health Chemical Diversity Library for multistage-active starting points for next-generation antimalarials. Acs Infectious Diseases |
| LaMonte GM, Orjuela-Sanchez P, Calla J, et al. (2019) Dual RNA-seq identifies human mucosal immunity protein Mucin-13 as a hallmark of Plasmodium exoerythrocytic infection. Nature Communications. 10: 488 |
| Antonova-Koch Y, Meister S, Abraham M, et al. (2018) Open-source discovery of chemical leads for next-generation chemoprotective antimalarials. Science (New York, N.Y.). 362 |